Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. (Q34382805)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

J Cuzick

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M Baum

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

A Buzdar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M Dowsett

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

J F Forbes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

G Hoctin-Boes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

J Houghton

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

G Y Locker

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

J S Tobias

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

ATAC Trialists' Group

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

English

0 references

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

365

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

9453

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

60-62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917666-6

7 January 2021

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917666-6

7 January 2021

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety upda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917666-6

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917666-6

7 January 2021

Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917666-6

7 January 2021

10.1016/S0140-6736(04)17666-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15639680%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference